EntryPoint Capital’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,460
Closed -$11.2K 1246
2024
Q1
$11.2K Buy
+1,460
New +$11.2K 0.01% 1217